Quarterly report · Q2
4582.TEDINET S100OVUS
Period2022-01-01 → 2022-06-30
Filed2022-08-05
StandardJapan GAAP
ConsolidatedYes
Data checks8 of 8 passed
Key figures · 19
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.9bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥1.4bn | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.4bn | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.6bn | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.1bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.1bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥9.6bn | at 2022-06-30 | Cons. | Assets |
| Total liabilities | ¥1.2bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥8.4bn | at 2022-06-30 | Cons. | Net assets |
| Cash and deposits | ¥5.8bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.8bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.9bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.2bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥6m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥637m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥28.71 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.36 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥28.32 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 83.6% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 288
| Item | Context | Value | Unit |
|---|---|---|---|
| Decrease increase in other current assets ope cf | CurrentYTDDuration | -303641000 | JPY |
| Increase decrease in other current liabilities ope cf | CurrentYTDDuration | -113856000 | JPY |
| Other net ope cf | CurrentYTDDuration | 156280000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 1451712000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 29000 | JPY |
| Commitment fee paid ope cf | CurrentYTDDuration | -47590000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -240360000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 1163790000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -2034000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -4407000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | CurrentYTDDuration | 432000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -6009000 | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | CurrentYTDDuration | 103000 | JPY |
| Proceeds from issuance of subscription rights to shares fin cf | CurrentYTDDuration | 13760000 | JPY |
| Payments for issuance of common stock fin cf | CurrentYTDDuration | -38193000 | JPY |
| Proceeds from issuance of common stock fin cf | CurrentYTDDuration | 662000000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -1052000 | JPY |
| Proceeds from disposal of treasury stock fin cf | CurrentYTDDuration | 81000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | 636699000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 137585000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 1932065000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 3860106000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | CurrentYTDDuration | 13637000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 5805810000 | JPY |
| Promotion expenses sga | CurrentYTDDuration | 836580000 | JPY |
| Directors compensations sga | CurrentYTDDuration | 61500000 | JPY |
| Payroll and allowances sga | CurrentYTDDuration | 239828000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 421000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 1009402000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-08-05 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第18期第２四半期(自 2022年４月１日 至 2022年６月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)シンバイオ製薬株式会社 | |
| Company name in english cover page | FilingDateInstant | SymBio Pharmaceuticals Limited | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長兼CEO 吉田 文紀 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区虎ノ門三丁目２番２号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03(5472)1125 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)財務経理部長 畔栁 隆次 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区虎ノ門三丁目２番２号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03(5472)1125 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)財務経理部長 畔栁 隆次 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E24682 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45820 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)シンバイオ製薬株式会社 | |
| Filer name in english | FilingDateInstant | SymBio Pharmaceuticals Limited | |
| Fund name in japanese | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 8 of 8 passed
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |